Apotheka acquires two pharmacy outlets from Panpharmacy
In a strategic move that signifies the ongoing consolidation and growth within the Latvian pharmaceutical retail sector, Panpharmacy, the parent company of the leading online pharmacy InternetAptieka.lv, has successfully completed the sale of two of its brick-and-mortar pharmacies to Apotheka. These pharmacies, both situated in the capital city of Riga, will continue to serve customers under the Apotheka brand, marking a seamless transition in ownership and operations.
InternetAptieka.lv is recognized as the premier online pharmacy platform in Latvia, offering a wide range of pharmaceutical products and health-related services to its customers. This divestiture allows Panpharmacy to potentially refocus resources and further strengthen its leading position in the digital pharmacy space.
Apotheka is a prominent name in the Latvian pharmaceutical retail landscape. The company currently operates more than 120 pharmacies across Latvia, with a significant presence in Riga as well as major cities such as Liepaja, Ventspils, Jelgava, Daugavpils and Rezekne. Apotheka is part of Magnum Group, a leading group in pharmaceutical wholesaling and retailing in the Baltic States.
Oaklins’ team in Latvia acted as the exclusive M&A advisor to Panpharmacy and its shareholders.
Contáctese con el equipo de la transacción
Transacciones relacionadas
AWC has acquired a significant minority stake in MyFitness
AWC AS, the investment company of the Norwegian family office Awilhelmsen, has acquired a 22.2% stake in MyFitness AS, the largest fitness club operator in the Baltics, becoming the MyFitness’ largest single shareholder.
Conozca másKaviari has received a minority investment from idiCo
Kaviari has received a minority investment from a pool of investors led by idiCo, alongside Bpifrance, IRD Invest and UI Investissement.
Conozca másInstituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Conozca más